✦ LIBER ✦

KRAS Testing in Metastatic Colorectal Cancer: Implications on the Use of Biologic Agents

✍ Scribed by Tanios Bekaii-Saab

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integration of Biologic Agents With Cyto

✍ Vikram K. Jain; Eliza A. Hawkes; David Cunningham 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 588 KB

KRAS mutation testing of metastatic colo

✍ Scott, Rodney J.; Fox, Stephen B.; Desai, Jayesh; Grieu, Fabienne; Amanuel, Benh 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Cost-effectiveness of KRAS testing in me

✍ Arthi Vijayaraghavan; Molly B. Efrusy; Burkhard Göke; Thomas Kirchner; Christoph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 394 KB

KRAS, BRAF, PIK3CA, and PTEN mutations:

✍ Wendy De Roock; Veerle De Vriendt; Nicola Normanno; Fortunato Ciardiello; Sabine 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 166 KB

KRAS mutational status assessment in pat

✍ M. HEBBAR; P. FOURNIER; O. ROMANO 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

BRAF,KRAS, and Phosphatidylinositol 3-Ki

✍ Coutinho, Anelisa K.; Prolla, Gabriel; Weschenfelder, Rui 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 308 KB